FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称BEVUFENOGENE NOFEPARVOVEC
异名/同义词A NON-REPLICATING, RECOMBINANT ADENO-ASSOCIATED VIRUS, HEMATOPOIETIC STEM CELL SEROTYPE 15 (AAVHSC15) EXPRESSING CODON-OPTIMISED HUMAN PHENYLALANINE HYDROXYLASE (PAH) UNDER CONTROL OF A LIVER-SPECIFIC HYBRID PROMOTER (COMPRISING HUMAN HEPATIC CONTROL REGION-1 (HCR-1) ENHANCER ELEMENT, HUMAN ALPHA-1-ANTITRYPSIN (HAAT) PROMOTER AND THE SV40 SMALL T INTRON)) AND AN SV40 POLYA SIGNAL SEQUENCE, FLANKED BY ADENO-ASSOCIATED VIRUS 2 (AAV2) INVERTED TERMINAL REPEATS (ITRS)
BEVUFENOGENE NOFEPARVOVEC
BEVUFENOGENE NOFEPARVOVEC [INN]
BEVUFENOGENE NOFEPARVOVEC [USAN]
DNA (RECOMBINANT HUMAN HEMATOPOIETIC STEM CELL-DERIVED ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE AAVHSC15 HUMAN LIVER-SPECIFIC EXPRESSION CASSETTE INCLUDING HUMAN PHENYLALANINE 4-HYDROXYLASE CODON-OPTIMIZED CDNA PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS)
HMI-102
CAS登记号2374772-30-0
物质唯一标识(Unique Ingredient Identifier)W6GL3Z8KWT
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System